Clinical Trial Update: Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Acitretin Capsules [Phase 2]

View source ↗

Summary

A Phase 2 pharmacogenomics study is evaluating acitretin capsules for psoriasis vulgaris; current status is listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Acitretin (Acitretin)

Snippet

Sponsor: Central South University | Conditions: Psoriasis Vulgaris | Phase 2 | Status: UNKNOWN